In part 1 of this 2-part preview of AAPS PharmSci 360’s keynote on predictive drug development, Robert Holt, PhD, associate ...
On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In ...
The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...
Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...
FDA approves Rasonque (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer, validating RAS ...
This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...
Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...
On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...
McKesson plans to absorb Precision Medicine Group into Oncology & Multispecialty, adding CRO, lab, biomarker, market access, and commercialization capabilities to its existing healthcare services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results